Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus SODIUM ACETATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus SODIUM ACETATE.
CALCIUM GLUCEPTATE vs SODIUM ACETATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium gluceptate is a calcium salt that dissociates to provide calcium ions, which are essential for various physiological processes including nerve conduction, muscle contraction, blood coagulation, and cardiac function. It acts as a calcium replenisher.
Sodium acetate provides sodium ions and acetate ions. Acetate is metabolized to bicarbonate, which acts as a buffer to correct metabolic acidosis.
IV: 2-4 mg/kg elemental calcium (5-10 mL of 0.45 mEq/mL solution) administered slowly over 10-20 minutes. May repeat if needed. Maximum dose: 20 mL per infusion.
Intravenous: 50-200 mL of 0.1-0.4 mEq/mL solution per dose; administer at a rate not exceeding 1 mEq/kg/hour; frequency based on serum bicarbonate and acid-base status.
None Documented
None Documented
Terminal elimination half-life: 2-4 hours (normal renal function); prolonged to 12-24 hours in renal impairment.
2-3 minutes (rapid conversion to bicarbonate in circulation). Clinical context: Exogenous acetate (e.g., in parenteral nutrition) is quickly cleared, limiting duration of alkalinizing effect.
Renal: >90% excreted unchanged in urine. Biliary/fecal: <5%.
Primarily renal; acetate is rapidly metabolized to bicarbonate via the Krebs cycle, with less than 5% excreted unchanged in urine.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement